Inventor · disambiguated record
Joseph Y. Tai
Also filed as: MICHON FRANCIS · TAI JOSEPH · TAI JOSEPH Y
14 granted patents·7 pending applications·575 citations·filing 1983–2005
94Inventor score
Files withNORTH AMERICAN VACCINE INC8BAXTER INT4GLOBAL CANCER STRATEGIES LTD1MERCK & CO INC1TZE JOHN W1
Top patents by PatentIndex Score
21 records- 0194US4459286ACoupled H. influenzae type B vaccineMERCK & CO INC·Filed 1983·Granted Jul 10, 1984·211 cites·7 claims
- 0292US5439808AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1993·Granted Aug 8, 1995·97 cites·19 claims
- 0386US7332173B2Group A streptococcal polysaccharide immunogenic compositions and methodsUNIV ROCKEFELLER·Filed 2005·Granted Feb 19, 2008·3 cites·20 claims
- 0486US5425946AVaccines against group C Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1992·Granted Jun 20, 1995·73 cites·9 claims
- 0582US6602508B2Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccineBAXTER INT·Filed 2001·Granted Aug 5, 2003·11 cites·2 claims
- 0682US5879686AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted Mar 9, 1999·35 cites·14 claims
- 0781US6013267AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted Jan 11, 2000·31 cites·19 claims
- 0875US6372222B1Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereofBAXTER INT·Filed 1998·Granted Apr 16, 2002·41 cites·16 claims
- 0970US5866135AGroup A streptococcal polysaccharide immunogenic compositions and methodsNORTH AMERICAN VACCINE INC·Filed 1994·Granted Feb 2, 1999·32 cites·49 claims
- 1064US6764686B2Modified immunogenic pneumolysin compositions as vaccinesBAXTER INT·Filed 1998·Granted Jul 20, 2004·15 cites·34 claims
- 1155US5747287AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted May 5, 1998·17 cites·13 claims
- 1254US2005070695A1Modified immunogenic pneumolysin compositions as vaccinesFiled 2004·Application pending·0 cites
- 1353US2006165816A1Herbal compositions useful as chemopreventive and therapeutic agentsTZE JOHN W·Filed 2002·Application pending·0 cites
- 1453US2005025841A1Therapeutic methods using herbal compositionsFiled 2002·Application pending·0 cites
- 1552US2004192579A1Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseasesFiled 2002·Application pending·0 cites
- 1652US2004170704A1Process for the manufacture of a herbal compositionFiled 2002·Application pending·0 cites
- 1751US2003099725A1Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing sameGLOBAL CANCER STRATEGIES LTD·Filed 2001·Application pending·0 cites
- 1847US6153406AMethod for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type BNORTH AMERICAN VACCINE INC·Filed 1993·Granted Nov 28, 2000·8 cites·41 claims
- 1945US2002058042A1Non-IgA fc binding forms of the Group B streptococcal beta antigensFiled 2001·Application pending·0 cites
- 2030US6280738B1Non-IgA Fc binding forms of the group B streptococcal β antigensBAXTER INT·Filed 1997·Granted Aug 28, 2001·1 cites·12 claims
- 2124US6284884B1Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereofNORTH AMERICAN VACCINE INC·Filed 1995·Granted Sep 4, 2001·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Joseph Y. Tai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →